Cancerous phenotypes associated with hypoxia-inducible factors are not influenced by the volatile anesthetic isoflurane in renal cell carcinoma
Authors:
- Chisato SumiCSChisato Sumi
- Munenori KusunokiMKMunenori Kusunoki
- Tomohiro ShojiTSTomohiro Shoji
- Takeo UbaTUTakeo Uba
- Teppei IwaiTITeppei Iwai
- Hidemasa BonoHidemasa Bono
- Kiichi HirotaKiichi Hirota
Preprint
Abstract
The possibility that anesthesia during cancer surgery may affect cancer recurrence, metastasis, and patient prognosis has become one of the most important topics of interest in cancer treatment. For example, the volatile anesthetic isoflurane was reported in several studies to induce hypoxia-inducible factors, and thereby enhance malignant phenotypes in vitro . Indeed, these transcription factors are considered critical regulators of cancer-related hallmarks, including “sustained proliferative signaling, evasion of growth suppressors, resistance to cell death, replicative immortality, angiogenesis, invasion, and metastasis.” This study aimed to investigate the impact of isoflurane on the growth and migration of derivatives of the renal cell line RCC4. We indicated that isoflurane treatment did not positively influence cancer cell phenotypes, and that hypoxia-inducible factors (HIFs) maintain hallmark cancer cell phenotypes including gene expressions signature, metabolism, cell proliferation and cell motility. The present results indicate that HIF activity is not influenced by the volatile anesthetic isoflurane.Keywords
All Related Versions
- Published version: PLOS ONE, 14 (4), e0215072.
This publication has 27 references indexed in Scilit:
- Isoflurane, a Commonly Used Volatile Anesthetic, Enhances Renal Cancer Growth and Malignant Potential via the Hypoxia-inducible Factor Cellular Signaling Pathway In VitroAnesthesiology, 2013
- Hydrogen Sulfide Inhibits Hypoxia- But Not Anoxia-Induced Hypoxia-Inducible Factor 1 Activation in a von Hippel-Lindau- and Mitochondria-Dependent MannerAntioxidants & Redox Signaling, 2012
- General Anesthetics Inhibit Erythropoietin Induction under Hypoxic Conditions in the Mouse BrainPLOS ONE, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Ensembl BioMarts: a hub for data retrieval across taxonomic spaceDatabase: The Journal of Biological Databases and Curation, 2011
- Hypoxia‐inducible factor 1 and cancer pathogenesisIUBMB Life, 2008
- Hypoxia-inducible factors: central regulators of the tumor phenotypeCurrent Opinion in Genetics & Development, 2007
- Targeting HIF-1 for cancer therapyNature Reviews Cancer, 2003
- Hypoxia-inducible factor 1, a master transcription factor of cellular hypoxic gene expressionJournal of Anesthesia, 2002
- The Hallmarks of CancerCell, 2000